State of the
Art:
Acute Ischemic Stroke Management
Monday, September
5, 2005
Nice, France
This symposium was
supported in part through an unrestricted educational grant
from AstraZeneca Neuroscience.
|
Future
Therapeutic Modalities for Acute Ischemic Stroke: |
|
The
Impact of Designated Stroke Centers: |
|
Evaluating
ED Patients with a Transient Ischemic Attack: |
Background
Ischemic stroke and other cerebrovascular accidents (CVAs) occur frequently, requiring urgent diagnostic testing and therapy for these patients in the Emergency Department. Because CVAs occur frequently, and because they cause significant disability, there have been consistent and successful enhancements in stroke management.
Dr. Barsan will discuss some of the advances in clot management, including the option to utilize thrombolytic therapy after the initial three hour window and the use of clot retrieval devices. Other stroke therapies that are currently being tested in the clinical setting, including neuroprotectants, will also be discussed.
In order to optimize the care of stroke patients, stroke center designation has been implemented. These centers allow not only facilitate stroke patient prehospital triage; they may also enhance the care that these patients receive because they are treated in dedicated stroke hospitals. Dr. Bunney will discuss the impact of stroke center designation on the care of acute CVA patients.
Lastly, there has been a move to standardize and expedite the care of patients who present to the Emergency Department with transient ischemic attacks (TIAs). Dr. Ross, who received an FERNE/EMF Neurological Emergencies Research Grant, will discuss his clinical trial that compared an outpatient protocol for the evaluation of TIA to traditional hospital admission.
Learning
Objectives
Upon completion of the program, participants should be able to: